Posts

Dupilumab + OIT for Food Allergy Desensitization

Biologics vs. JAK Inhibitors for Atopic Dermatitis: Which One Wins for Your Patient? A 2026 Practical Guide

2025: A Breakthrough Year for Chronic Urticaria - New FDA Approvals Reshaped Treatment

Tezepelumab vs. Dupilumab in Severe Asthma: Head-to-Head Real-World Data Shows No Clear Winner

Dupilumab-Induced Eosinophilia (DIBE) in CRSwNP Affected 48% of Patients

Dupilumab is very effective in difficult‐to‐treat adult atopic dermatitis patients

Dupilumab in real life: much higher frequency of conjunctivitis and eosinophilia reported

Dupilumab (Dupixent) dose for asthma: when do you use 200 mg vs. 300 mg?

Game Changer: Dupilumab Injections for Uncontrolled Asthma

Dupilumab Injections Improve Atopic Dermatitis